HorseFil Review 2026: Cardiac Safety Assessment

By UTCardiothoracicSurgery.com Editorial Team

FTC Disclosure: This article may contain affiliate links. We may earn a commission at no additional cost to you. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

UTCTS Health Review Editorial Team | July 2026

HorseFil and Cardiac Patients: What the UTCTS Editorial Team Found

Men over 40 managing heart conditions often face a double challenge: treating cardiovascular disease while maintaining vitality and sexual function. Erectile dysfunction affects roughly 40% of men at age 40, and the prevalence rises with age. More importantly, ED itself can signal underlying vascular disease in cardiac patients. Male vitality supplements like HorseFil market themselves as natural alternatives to prescription treatments, but for men on cardiac medications, this “natural” claim can mask serious drug interaction risks.

This review examines HorseFil specifically through the lens of cardiovascular safety. For a broader look at how supplements in this category affect cardiac patients, see our men's vitality supplements and cardiac patients guide. We are not here to declare whether HorseFil “works.” Instead, we document the ingredients, analyze how they interact with common cardiac medications, identify the dose gaps between label claims and clinical research, and present the evidence so cardiac patients and their cardiologists can decide together whether this product fits their health profile.

The UTCTS team's core finding: HorseFil poses low acute cardiovascular risk at labeled doses, but the presence of Horny Goat Weed (icariin) and L-Arginine creates theoretical pathways for drug interactions that cardiac patients should acknowledge and discuss with their cardiologist before use.

HorseFil Ingredient Profile: A Cardiovascular Assessment

Important note on dose comparisons: HorseFil's label does not disclose extract standardization details (e.g., percentage of active compounds like eurycomanone in Tongkat Ali or withanolides in Ashwagandha). Clinical studies typically use standardized extracts with verified active compound concentrations. Without this information, direct dose-to-dose comparisons between HorseFil and clinical trial protocols are approximate and should be interpreted with caution.

L-Arginine HCl (50mg): This amino acid affects the nitric oxide pathway, which controls blood vessel relaxation and blood pressure. L-Arginine is studied at doses of 1,500–5,000mg daily in clinical trials. HorseFil delivers 50mg per gummy (well below clinical study doses). At this concentration, L-Arginine likely contributes minimally to direct cardiovascular effects, but the mechanism is relevant for cardiac patients. Anyone on blood pressure medications should note that arginine theoretically lowers blood pressure, though evidence at 50mg is limited.

Tongkat Ali Extract (200mg): Tongkat Ali (Eurycoma longifolia) is studied for testosterone support and male sexual function. Clinical trials use doses of 200–600mg daily. Studies on Tongkat Ali have shown improvements in sexual function parameters (Thu et al., 2017; Ismail et al., 2012). HorseFil's 200mg matches the lower end of clinical range — actually one of the better-dosed ingredients in this formula. Research suggests Tongkat Ali may have mild blood pressure elevating effects in some studies, though findings are inconsistent. Cardiac patients on antihypertensive therapy should monitor this, though the effect size is typically small.

Maca Root Extract (100mg): Peruvian maca is traditionally used for energy and sexual function. Clinical studies use 1,500–3,600mg daily. HorseFil's 100mg is 15–36% of a clinical dose. At this level, maca's effects are likely subtle and primarily traditional/placebo-driven rather than evidence-backed. Cardiovascular risk from maca is minimal and not well-documented.

Ashwagandha Extract (100mg): Ashwagandha (Withania somnifera) is an adaptogenic herb studied for stress and testosterone support. Clinical doses range 300–1,200mg daily. HorseFil's 100mg is below typical clinical doses. Importantly, ashwagandha can interact with thyroid medications (commonly used in cardiac patients with metabolic comorbidities) and may potentiate beta-blocker effects. Cardiac patients on levothyroxine or propranolol should discuss this ingredient with their cardiologist.

Horny Goat Weed Extract (100mg) — A NOTABLE CONSIDERATION: This ingredient contains icariin, a weak phosphodiesterase-5 (PDE5) inhibitor. PDE5 inhibitors are the active mechanism in sildenafil (Viagra) and tadalafil (Cialis). For cardiac patients, this is not theoretical — it is actionable safety information. Patients on nitrates (nitroglycerin, isosorbide) should not combine nitrates with PDE5 inhibitors without physician clearance due to severe hypotension risk (documented cardiovascular emergencies). Patients on PDE5 inhibitors prescribed for erectile dysfunction should not combine with additional PDE5-active supplements. Icariin's activity is weaker than pharmaceutical PDE5i, but the pathway is the same. A cardiac patient on nitroglycerin who takes HorseFil is creating a theoretical interaction risk that warrants precautionary avoidance, even though HorseFil's actual icariin concentration is unknown.

Beet Root Extract (50mg) & Grape Seed Extract (50mg): Beet root increases nitric oxide and supports endothelial function — potentially beneficial for circulation but not relevant at 50mg. Grape seed supports vascular endothelium and antioxidant defenses. Based on available evidence, neither ingredient has documented interaction risks at these doses, though cardiac patients should still mention all supplements to their cardiologist.

HorseFil Dosing Analysis: Clinical Thresholds vs. Gummy Reality

One critical pattern emerges when comparing HorseFil's labeled doses to clinical research: only Tongkat Ali approaches evidence-based dosing. Everything else is significantly underdosed.

The gummy format is the limiting factor. Gummies require smaller ingredient volumes than capsules, and they need binding agents and sweeteners that take up space. As a result, most HorseFil ingredients are present at 50–100mg — exactly 10–33% of the doses used in clinical research. This is not necessarily “bad,” but it is important: readers should understand that this formula is not equivalent to a clinical trial dose. The marketing may suggest clinical efficacy, but the doses do not support it.

Tongkat Ali at 200mg is the exception. This dose matches lower-end clinical range and may provide noticeable effects. The other six ingredients are placeholder amounts — likely chosen to create label diversity and indicate “clinically researched” ingredients without actually delivering clinical doses. This is standard supplement industry practice, but cardiac patients need to recognize the gap.

For male vitality specifically: research on erectile dysfunction in cardiac patients shows that underlying cardiovascular disease, not supplement deficiency, is usually the root cause. A man with atherosclerosis or heart failure will not be meaningfully helped by 50mg of L-arginine. His cardiologist's evaluation, medication management, and potentially prescribed PDE5 inhibitors with proper cardiac clearance are the evidence-based approach. Our L-Citrulline and nitric oxide evidence review covers the vascular pathways involved.

Drug Interaction Warnings for HorseFil Users with Cardiac Conditions

The following medication classes are commonly prescribed to cardiac patients. HorseFil creates documented or theoretical interactions with several:

Nitrates (Nitroglycerin, Isosorbide Dinitrate, Isosorbide Mononitrate): IMPORTANT INTERACTION. Horny Goat Weed contains icariin (PDE5 inhibitor activity). PDE5 inhibitors + nitrates can cause severe, life-threatening hypotension. Cardiac patients on any nitrate therapy should not take HorseFil without physician clearance. This is not a borderline interaction — it is a documented contraindication.

PDE5 Inhibitors (Sildenafil, Tadalafil, Vardenafil): Combining two PDE5-active substances (Horny Goat Weed's icariin + prescribed PDE5i) increases hypotension and adverse event risk. Not impossible to combine with medical supervision, but redundant and unnecessary. Cardiologists generally do not recommend this stacking.

Beta-Blockers (Metoprolol, Carvedilol, Atenolol): Ashwagandha may potentiate beta-blocker effects, potentially causing excessive bradycardia or hypotension. Risk is low at 100mg, but monitoring is appropriate. Patients on beta-blockers should check with their cardiologist before using products containing ashwagandha.

ACE Inhibitors (Lisinopril, Enalapril, Ramipril): No direct interaction documented. L-Arginine theoretically enhances ACE inhibitor effects on the nitric oxide pathway, but evidence is limited and risk is low. Safe for most patients, though blood pressure monitoring is prudent.

Antihypertensives (Amlodipine, Diltiazem, Verapamil): L-Arginine and Tongkat Ali may have mild blood-pressure effects. Combined with calcium channel blockers, risk of excessive hypotension is low but not zero. Blood pressure monitoring advised.

Statins (Atorvastatin, Rosuvastatin): No documented interactions at these doses based on available literature. However, patients on statins should inform their physician of any new supplement use.

Thyroid Medications (Levothyroxine): Ashwagandha can interfere with thyroid function and may interact with levothyroxine. Patients on thyroid replacement should discuss ashwagandha-containing products with their endocrinologist or cardiologist.

Warfarin and Other Blood Thinners: Grape Seed Extract has mild anticoagulant properties. At 50mg, interaction risk with warfarin is minimal, but patients on warfarin should inform their cardiologist of any supplement use, including HorseFil, and have INR checked after 2–3 weeks if started.

HorseFil Label vs. Marketing Claims: What We Verified

The HorseFil Supplement Facts panel is transparent about ingredient amounts and ingredients themselves. No proprietary blends hide undisclosed ingredients, which is a positive signal. The label clearly states “Suggested Use: 1 gummy daily, 20–30 minutes before meal.”

Marketing language on the website emphasizes “natural male vitality,” “powerful formula,” and “backed by research.” These claims are vague but not false — the ingredients ARE studied in research, though not at HorseFil's doses. The marketing does not explicitly claim HorseFil is safe for cardiac patients or compatible with cardiac medications. It also does not disclose the icariin-nitrate interaction, which is the biggest oversight from a safety perspective.

The 60-day money-back guarantee is legitimate and suggests confidence in the product. For cardiac patients, this warranty is irrelevant compared to the need for pre-use medical discussion.

Pricing and Refund Terms

HorseFil pricing is tiered by bulk purchase: $79 for a single bottle, $69 per bottle in a 3-pack, and $49 per bottle in a 6-pack. Each bottle contains 30 servings (gummies), so cost per serving ranges from $1.63–$2.63. This is mid-range pricing for male vitality supplements.

The 60-day money-back guarantee covers full refund if customers are unsatisfied, with returns processed through the manufacturer. No details on shipping return costs are disclosed on the label itself (consult horsefil.com for return logistics).

Pricing is subject to change. Verify current pricing on the manufacturer's official listing.

Cardiac Patient Eligibility and Recommendations

The UTCTS team's assessment: HorseFil is not recommended for cardiac patients on nitrates or PDE5 inhibitors as a precaution, given that Horny Goat Weed shares a mechanism with PDE5 inhibitors even though HorseFil's icariin concentration is undisclosed. For other cardiac patients, the product poses low acute risk at labeled doses, but the formula's subtherapeutic ingredient amounts limit its utility. The real issue is not that HorseFil is dangerous — it is that it is unlikely to address the root cause of male sexual dysfunction in cardiac patients, which is usually cardiovascular disease itself, not botanical deficiency.

Cardiac patients experiencing erectile dysfunction should prioritize cardiologist evaluation of their underlying cardiovascular status and medication regimen. Many cardiac medications (beta-blockers, diuretics) can worsen ED as a side effect, and optimization of these medications often improves function. If additional support is needed, prescription PDE5 inhibitors with proper cardiac clearance are evidence-based. Supplements like HorseFil, even if safe to combine, do not replace medical evaluation. For a similar product reviewed through this lens, see our HeroMD 4MAX cardiac safety review.

Who this is NOT for: Patients on nitrates. Patients on PDE5 inhibitors without cardiologist approval of combined use. Patients on beta-blockers or thyroid medications (ashwagandha interaction requires medical discussion first). Patients with undiagnosed ED who should see a cardiologist before self-treating.

Who might find this relevant: Cardiac patients with stable disease, good medication adherence, and normal blood pressure who want an additional natural vitality support and have discussed HorseFil with their cardiologist first. Even then, the underdosed ingredients limit efficacy beyond placebo.

Frequently Asked Questions About HorseFil

Can cardiac patients take HorseFil?

Cardiac patients should consult their cardiologist before taking HorseFil. Patients on nitrate medications should not take HorseFil without physician clearance due to Horny Goat Weed's PDE5 inhibitor-like activity. Patients on beta-blockers or thyroid medications should also discuss potential interactions with their doctor.

Does HorseFil interact with heart medications?

HorseFil contains Horny Goat Weed (icariin), which has PDE5 inhibitor-like activity and may interact with nitrate medications and prescription PDE5 inhibitors. Ashwagandha may interact with beta-blockers and thyroid medications. L-Arginine affects the nitric oxide pathway. Discuss any supplement use with your cardiologist.

Is HorseFil safe for blood pressure patients?

L-Arginine and Tongkat Ali may have mild blood pressure effects. While risk appears low at HorseFil's doses, patients on antihypertensive medications should monitor blood pressure and inform their cardiologist. The combination of multiple ingredients affecting vascular function warrants medical oversight.

Should I take HorseFil instead of ED medication?

HorseFil is not a replacement for prescription ED medications. For cardiac patients, ED often signals underlying cardiovascular disease that requires medical evaluation. Prescription PDE5 inhibitors with proper cardiac clearance are the evidence-based approach for ED in cardiac patients.